ARVN · Arvinas, Inc. · Investor Relations
$7.88
-0.02 (-0.25%)
At close · Oct 30
Return incl. dividend (before tax)
Q2 2026 earnings call transcript
Market Cap
$516.55M
Shares
65.39M
Volume · Oct 30
205.9K
Avg daily vol (3M)
817.13K
Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Upcoming events
| Date | Event | Type |
|---|---|---|
| 2026-11-03 13:00 UTC | Arvinas 3Q26 Earnings Call | Earnings call |
Past events
| Date | Event | Type |
|---|---|---|
| 2026-09-17 | Morgan Stanley Annual Global Healthcare Conference | Conference |
| 2026-09-10 | Cantor Global Healthcare Conference | Conference |
| 2026-09-08 | Wells Fargo 21st Annual Healthcare Conference | Conference |
| 2026-08-04 | Arvinas 2Q26 Earnings Call | Earnings call |
| 2026-06-03 | Jefferies Global Healthcare Conference | Conference |
| 2026-05-12 | Arvinas 1Q26 Earnings Call | Earnings call |
| 2026-02-24 | Q4 Earnings conference call (announced in 8-K) | Earnings call |
Source: http://ir.arvinas.com/
Key facts
CIK
1655759
CUSIP
04335A105
13F (30d)
37 filings
34 filers
Visit website
Investor relations